OncoDNA, Tamkin Al-Seha Medical and Bayer Saudi Arabia announced today a new partnership to broaden access to Neurotrophic Tyrosine Receptor Kinase (NTRK) biomarker testing and identify patients eligi...
Read moreResearch led by VHIO investigators represents a step forward in better understanding the underlying mechanisms that drive disease progression in chronic lymphocytic leukemia (CLL).
Read moreThe successful candidates will conduct their research at CIC bioGUNE. The aim of the collaboration agreement is to improve equal opportunity, universal accessibility, inclusion and non-discrimination...
Read moreEn la fase aguda de la infección por el coronavirus SARS-CoV-2, los niveles en sangre de la proteína ACE2, a la que se une el virus para entrar en las células, están significativamente reducidos e...
Read moreCombining chemotherapy and BRAF oncogene inhibitors is a very effective strategy for fighting metastatic melanoma, the leading cause of death from skin cancer in the world.
Read moreThe research group on Emergent and Translational Microbiology at ibs.GRANADA, has launched a new web application called "RESBAC", which is already being used by health personnel at the Virgen de las N...
Read moreAn international collaboration uncovers several genetic markers associated with SARS-CoV-2 infection and COVID-19 severity. These results, which have been published in Nature, come from one of the lar...
Read moreUn trabajo del CIBERES publicado en mBio ofrece nuevas claves genómicas de la evolución adaptativa de bacterias patógenas en el pulmón de los pacientes con Enfermedad Pulmonar Obstructiva Crón...
Read moreLa iniciativa COVID-19 Host Genomics Initiative, cuenta con miles de investigadores distribuidos por todo el mundo con un objetivo común: conocer cómo influye la información genética en la suscept...
Read moreAlejo Efeyan's team at the CNIO has shown in animal models that blocking signals controlled by the RagC protein delays the onset of follicular lymphoma without side effects
Read moreAs some of you may know, Microptic team is composed of a combination of different profiles, each of them specialised in their field with the purpose of giving their best.
Read moreOryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today...
Read more